Keynote Speakers

Kanta Subbarao

Kanta Subbarao
Professor
University of Melbourne


Professor Kanta Subbarao is a virologist and a physician with specialty training in paediatrics and paediatric infectious diseases. She has worked on molecular virology and vaccine development for emerging viruses that pose a potential pandemic threat, including influenza viruses, SARS and MERS and now SARS-CoV-2 coronaviruses in a career spanning 30 years. Previously, she was Chief of the Molecular Genetics Section of the Influenza Branch at the Centers for Disease Control and Prevention (CDC) in Atlanta (1997-2002) and Chief of the Emerging Respiratory Viruses Section of the Laboratory of Infectious Diseases, of the National Institute of Allergy and Infectious Diseases (NIAID), NIH in the USA (2002-2016). In November 2016, she moved to Melbourne and the Peter Doherty Institute for Infection and Immunity. She is a Fellow of the Australian Academy of Health and Medical Sciences, American Academy of Microbiology and the Infectious Diseases Society of America. She serves on the Editorial Board of PLoS Pathogens, Cell Host and Microbe, Journal of Virology, Med, and Cell.

Nevan Krogan

Nevan Krogan

Nevan Krogan, PhD, is a molecular biologist, UC San Francisco professor, and director of the intensely interdisciplinary Quantitative Biosciences Institute (QBI) under the UCSF School of Pharmacy. He is also a senior investigator at the Gladstone Institutes.
 
He led the work to create the SARS-CoV-2 interactome and assembled the QBI Coronavirus Research Group (QCRG), which includes hundreds of scientists from around the world. His research focuses on developing and using unbiased, quantitative systems approaches to study a wide variety of diseases with the ultimate goal of developing new therapeutics. 
 
Nevan serves as Director of The HARC Center, an NIH-funded collaborative group that focuses on the structural characterization of HIV-human protein complexes. Dr. Krogan is also the co-Director of three Cell Mapping initiatives, the Cancer Cell Mapping Initiative (CCMI), the Host Pathogen Map Initiative (HPMI) and the Psychiatric Cell Map Initiative (PCMI).  These initiatives map the gene and protein networks in healthy and diseased cells with these maps being used to better understand disease and provide novel therapies to fight them.
 
He has authored over 250 papers in the fields of genetics and molecular biology and has given over 350 lectures and seminars around the world. He is a Searle Scholar, a Keck Distinguished Scholar, and was recently awarded the Roddenberry Prize for Biomedical Research.